Web Results

Alefacept

en.wikipedia.org/wiki/Alefacept

Alefacept is a genetically engineered immunosuppressive drug. It was sold under the brand name Amevive in Canada, the United States, Israel, Switzerland and ...

Amevive (alefacept) voluntarily discontinued in the U.S. | National ...

www.psoriasis.org/media/press-releases/amevive-alefacept-voluntarily-discontinued-us

Nov 16, 2011 ... Astellas Pharma U.S. Inc. (Astellas) has voluntarily discontinued the promotion, manufacturing, distribution and sales of Amevive (alefacept), ...

AMEVIVE (alefacept) DESCRIPTION CLINICAL PHARMACOLOGY

www.astellas.us/docs/amevive.pdf

AMEVIVE® (alefacept) is an immunosuppressive dimeric fusion protein that consists ... AMEVIVE® for intramuscular injection contains 15 mg alefacept, 12.5 mg ...

The safety and efficacy of alefacept in the treatment of chronic ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2386357/

Alefacept is the first biological agent approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe chronic plaque psoriasis.

Alefacept, Amevive, Biogen Inc, Package Insert - U.S. Food and ...

www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm086009.pdf

intravenous injection contains 7.5 mg alefacept per 0.5 mL of reconstituted solution. ... administration, the mean volume of distribution of alefacept was 94 mL/kg, ...

alefacept, Amevive: Drug Facts, Side Effects and Dosing - MedicineNet

www.medicinenet.com/alefacept/article.htm

Jun 11, 2015 ... Alefacept (Amevive) medication for adults with moderate to severe placuqe psoriasis. Side effects, dosage, pregnancy safety information, and ...

Alefacept | DermNet New Zealand

www.dermnetnz.org/topics/alefacept/

Alefacept (amevive). Authoritative facts about the skin from DermNet New Zealand.

Amevive (alefacept) - CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/820/amevive-alefacept

Amevive (alefacept): For moderate to severe chronic plaque psoriasis.. New approved drug details including side effects, uses and general information.

Amevive (alefacept) dosing, indications, interactions, adverse effects ...

reference.medscape.com/drug/amevive-alefacept-343188

Medscape - Indication-specific dosing for Amevive (alefacept), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

JCI - Alefacept provides sustained clinical and immunological effects ...

www.jci.org/articles/view/81722

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. Mark R. Rigby,<sup>1</sup> Kristina M. Harris,<sup>2</sup> Ashley Pinckney,<sup>3</sup> ...

More Info

Amevive (Alefacept): Side Effects, Interactions, Warning, Dosage ...

www.rxlist.com

AMEVIVE® (alefacept) is a CD2-directed LFA-3/Fc fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 ...

Amevive (alefacept) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com

Amevive (alefacept) is a protein that reduces specific actions of the immune system that are involved in causing psoriasis. Amevive is used to treat plaque ...

Alefacept - LiverTox - National Institutes of Health

livertox.nlm.nih.gov

Alefacept is a recombinant fusion protein of lymphocyte function associated antigen-3 (LFA-3) and immunoglobulin G dimer that acts to inactive T cells, and is an ...